Wobble Genomics, a biotechnology company specialising in improving cancer outcomes through better diagnosis and therapy ...
The research also revealed that the citrullinated form of CAMP contributed to an imbalance in microbial communities, impacting arginine metabolism, and promoting dendritic cell (DC) maturation and ...
Pharmacosmos Therapeutics presented new investigator-sponsored research at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. The abstract, “CDK4/6 inhibition mitigates ...
Recently, Creative Biolabs, drawing on its experience in antibody preparation, research-grade production, and process development, has systematically streamlined this continuous workflow, ...
Quotient Sciences, a global drug development, research and manufacturing accelerator, and Intrepid Labs, AI specialists in ...
Danaher companies Integrated DNA Technologies (IDT), a specialist in genomics, and Beckman Coulter Life Sciences, a ...
The first patient has been enrolled in Thermo Fisher Scientific's new PPD CorEvitas Myasthenia Gravis (MG) Registry. This nationwide registry will collect data from MG patients across the United ...
Life science manufacturing company Thermo Fisher Scientific has received approval from the FDA for its Ion Torrent Oncomine Dx Target Test as a companion diagnostic (CDx) to identify patients eligible ...
Big Blue Ceiling has completed and activated its new ISO-5 (Class 100) optical cleanroom, a controlled research environment built to support next-generation work in computational optics, sensor ...
Vision Engineering, a specialist in ergonomic microscopy, stereo imaging, and metrology solutions, has launched its ProteQ Viso, a 3D digital stereo microscope with an 'autostereo' display that allows ...
Lab automation systems are customisable and this modularity is a key selling point ...
AI software company Faro Health has partnered with biotechnology company Recursion to optimise and accelerate clinical protocol design for Recursion’s portfolio of clinical-stage drug candidates. “To ...